wire - news in brief

Health - Feb 15
Health
Seven years after the introduction of flat-rate payments at Swiss hospitals, a major study has revealed a slight increase in readmission rates. Researchers from the University of Basel and the Cantonal Hospital of Aarau reported the findings in the journal JAMA Network Open. In January 2012, a flat-rate payment structure for inpatient hospital services was introduced across Switzerland in the form of the Swiss Diagnosis Related Groups (SwissDRG).
Social Sciences - Feb 15
Social Sciences

Those who set realistic goals can hope for a higher level of well-being. The key for later satisfaction is whether the life goals are seen as attainable and what they mean to the person, as psychologists from the University of Basel report in a study with over 970 participants.

Electroengineering - Feb 15
Electroengineering

EPFL researchers have developed a compact and efficient medium-frequency transformer. Their device is poised to enhance the flexibility and efficiency of tomorrow's smart grids and DC power distribution networks.


Category



Results 1 - 50 of 359.
1 2 3 4 5 8 Next »


Business / Economics - 14.02.2019

Administration - 14.02.2019

Materials Science - Environment - 14.02.2019
New additive provides fire protection for wood
New additive provides fire protection for wood
Together with BRUAG Fire Protection AG, Empa specialists have developed a new flame retardant for wood and wood-based materials.

Materials Science - Environment - 14.02.2019
New additive provides fire protection for wood-based materials
New additive provides fire protection for wood-based materials
Together with BRUAG Fire Protection AG, Empa specialists have developed a new flame retardant for wood and wood-based materials.

Innovation / Technology - Careers / Employment - 14.02.2019
"The smart living lab is at a pivotal moment in its development"
EPFL's smart living lab, located on the Fribourg campus, is at a pivotal moment in its development. Martin Gonzenbach, the lab's new director of operations, tells us why.

Pharmacology - Health - 13.02.2019
Novartis receives FDA approval for Egaten for the treatment of fascioliasis, a neglected tropical disease
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO   Fascioliasis, commonly known as liver fluke infes

Life Sciences - 13.02.2019
7 challenges facing research and investment in primary brain tumours
Johanna Joyce, Ludwig member, co-signs a position paper on the challenges the scientific community faces in the fight against primary brain tumours On the initiative of Cancer Research UK, an international panel of brain cancer researchers and clinicians assessed the most important challenges ahead in the development of effective treatmens for patients.

Environment - Innovation / Technology - 12.02.2019
Optimizing energy flows
Optimizing energy flows
Interdisciplinary, interconnected and oriented towards a sustainable future: These words describe Kristina Orehounig just as aptly as they describe the Empa laboratory "Urban Energy Systems", which she is heading since February 2018. She has chosen an unusual path to her current scientific discipline - but that is precisely what she sees as an advantage in her day-to-day research.

Computer Science / Telecom - History / Archeology - 12.02.2019

Life Sciences - 11.02.2019

Environment - Physics - 11.02.2019
"The Arctic atmosphere is key to understanding climate change"
This summer, 40 international scientists will participate in the GLACE expedition around Greenland in order to study the effects of climate change in that region.

Business / Economics - 11.02.2019
Happiness research: the long-term effects of life events are overestimated
Happiness research: the long-term effects of life events are overestimated
People are evidently no good at predicting their own happiness or unhappiness: key life events such as marriage, invalidity or the death of a partner affect well-being for less time than those affected think.

Environment - 08.02.2019
Targeting restoration measures to maximise ecological benefits
Today, very few Swiss rivers or streams still flow in a natural bed. Since the eighteenth century, around 15,000 kilometres of watercourses have been modified, engineered or channelised. The degradation of aquatic habitats has had a severe impact on biodiversity. To tackle this problem, the federal government has requested the cantons to restore around 4,000 kilometres of rivers and streams by 2090.

Innovation / Technology - Health - 07.02.2019
Lunaphore, an EPFL spin-off, brings its first product to market
Lunaphore, an EPFL spin-off, brings its first product to market
The first rapid screening test for cancer developed by EPFL spin-off Lunaphore is being released today.

Environment - 06.02.2019

Business / Economics - Mathematics - 06.02.2019

Business / Economics - 05.02.2019

Business / Economics - 05.02.2019

Pharmacology - Health - 05.02.2019
Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro

Physics - Innovation / Technology - 04.02.2019
A new EPFL fund rewards nine open science ideas
A new EPFL fund rewards nine open science ideas
The first call for proposal for the EPFL Open Science Fund attracted nearly 50 propositions. Nine projects were selected and will receive support to develop ideas fostering open and reproducible research on campus, and beyond. In September 2018, EPFL President Martin Vetterli announced the creation of the Open Science Fund to support the best ideas from everyone on campus with a total of CHF 3 Mio over the period 2019-2021.

Pharmacology - Health - 01.02.2019
CHMP recommends EU approval of Roche’s Tecentriq in combination with Avastin and chemotherapy as an initial treatment for lung cancer
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people

Pharmacology - Health - 01.02.2019
CHMP recommends EU approval of Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit

Environment - Business / Economics - 01.02.2019
Solar energy for a circular economy
A sustainable alternative to the fossil-based, energy-intensive production of fuels and basic products of the chemical industry, based solely on solar energy and universally available resources: This

Business / Economics - 31.01.2019
The corporate governance index, or how to measure the impact of certain corporate governance issues
The corporate governance index, or how to measure the impact of certain corporate governance issues
Although it is widely accepted that governance rules play a major role in the smooth running of businesses and contribute to market equilibrium, how can we measure businesses' degree of responsibility in this area?

Life Sciences - Environment - 30.01.2019
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Gardens in urban areas can harbor a remarkable diversity of species. This has been found by researchers from the University of Basel in a field study carried out with the support of private garden owners from the Basel region. Furthermore, the research team shows that nature-friendly garden management and design can largely compensate for the negative effects of urbanization on biodiversity.

Computer Science / Telecom - Innovation / Technology - 30.01.2019
Using artificial intelligence to save bees
A beekeeper teamed up with the Signal Processing Laboratory 5 and a group of EPFL students to develop an app that counts the number of Varroa mites in beehives.

Pharmacology - Health - 30.01.2019
Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) - other company programmes in AD continue
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her

Architecture - 29.01.2019

Innovation / Technology - Health - 29.01.2019
Implants from the 3D printer
3D printing is finding its way into industrial manufacturing. This technology and the increasing digitalization of design and manufacturing processes - keyword "Industry 4.0" - will also play a central role in medical technology in the future. A new technology transfer centre in the canton of Solothurn will help to transfer know-how from science to industry - and at the same time accelerate research.

Life Sciences - Chemistry - 28.01.2019
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.

Materials Science - Chemistry - 25.01.2019

Environment - 24.01.2019
Eawag at the 2019 World Economic Forum
Eawag at the 2019 World Economic Forum
A walk-through exhibition introduces people to innovative projects from various institutes.

Event - 24.01.2019

Innovation / Technology - Astronomy / Space Science - 23.01.2019
1 2 3 4 5 8 Next »